Matches in Wikidata for { <http://www.wikidata.org/entity/Q87824319> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q87824319 description "artículu científicu espublizáu en mayu de 2014" @default.
- Q87824319 description "im Mai 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q87824319 description "scientific article published on 05 May 2014" @default.
- Q87824319 description "wetenschappelijk artikel" @default.
- Q87824319 description "наукова стаття, опублікована в травні 2014" @default.
- Q87824319 name "Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study" @default.
- Q87824319 name "Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study" @default.
- Q87824319 type Item @default.
- Q87824319 label "Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study" @default.
- Q87824319 label "Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study" @default.
- Q87824319 prefLabel "Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study" @default.
- Q87824319 prefLabel "Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study" @default.
- Q87824319 P1433 Q87824319-873DA89F-EC1F-4BC3-88BB-BF824EACC6F9 @default.
- Q87824319 P1476 Q87824319-74F39444-BD55-4122-A696-38B9D19ACB4B @default.
- Q87824319 P2093 Q87824319-29E99E55-CA54-4BDF-9BF7-61E20819285F @default.
- Q87824319 P2093 Q87824319-3F8E7E55-FEF5-4C21-9A74-2AA5460C9328 @default.
- Q87824319 P2093 Q87824319-55CAEDEA-F347-4ED4-959E-B15BAE5E4DA5 @default.
- Q87824319 P2093 Q87824319-C14AE160-479D-4575-B367-A6FC8709927C @default.
- Q87824319 P2093 Q87824319-FF842759-01AB-4DCD-902B-FBDB8D54D54F @default.
- Q87824319 P304 Q87824319-B901303C-6F36-47F2-8174-9AD145FAE205 @default.
- Q87824319 P31 Q87824319-717449E3-3424-4B1F-87E4-605869282B9A @default.
- Q87824319 P356 Q87824319-029C7F32-048F-4F7A-83AC-BEDE942F48DA @default.
- Q87824319 P433 Q87824319-89262340-1629-46D1-B932-01419719C2B7 @default.
- Q87824319 P478 Q87824319-5B5294A0-6071-42A9-A450-90D266D0E062 @default.
- Q87824319 P577 Q87824319-7955CBA6-E6FE-4677-B6B7-43DD1CF44586 @default.
- Q87824319 P698 Q87824319-EB325853-B303-4460-8CD8-58F4E2B2A90A @default.
- Q87824319 P921 Q87824319-52D0212B-9412-499A-8709-54ED990D8BC6 @default.
- Q87824319 P921 Q87824319-EAC74283-135C-4291-BF31-B09A2917B4A3 @default.
- Q87824319 P921 Q87824319-F3413F0A-00F6-4A8B-BC2D-F25A0845E119 @default.
- Q87824319 P356 J.CLINTHERA.2014.04.001 @default.
- Q87824319 P698 24802860 @default.
- Q87824319 P1433 Q15716601 @default.
- Q87824319 P1476 "Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study" @default.
- Q87824319 P2093 "Bart L Clarke" @default.
- Q87824319 P2093 "Hjalmar Lagast" @default.
- Q87824319 P2093 "Jane A Cyran" @default.
- Q87824319 P2093 "John Fox" @default.
- Q87824319 P2093 "Jolene Kay Berg" @default.
- Q87824319 P304 "722-736" @default.
- Q87824319 P31 Q13442814 @default.
- Q87824319 P356 "10.1016/J.CLINTHERA.2014.04.001" @default.
- Q87824319 P433 "5" @default.
- Q87824319 P478 "36" @default.
- Q87824319 P577 "2014-05-05T00:00:00Z" @default.
- Q87824319 P698 "24802860" @default.
- Q87824319 P921 Q1586088 @default.
- Q87824319 P921 Q323936 @default.
- Q87824319 P921 Q725307 @default.